Columbia Cardiology has launched the Mitral & Tricuspid Center, dedicated to exploring the latest devices and treatments for patients with mitral and tricuspid valve disease.
Columbia cardiologists will lead at New York Valves 2024, a summit on structural heart disease innovations, from June 5-7, featuring Columbia faculty lectures and panels.
Kimberly's routine checkup led to a life-threatening pulmonary embolism crisis, highlighting the power of collaborative medical intervention for survival.
The REDUCE LAP-HF II trial found that an atrial shunt device did not improve outcomes for heart failure patients, though some researchers believe there may be subgroups who could benefit.
Brief pulses of ultrasound delivered to nerves near the kidney lowered blood pressure in people with drug-resistant hypertension, Columbia and NewYork-Presbyterian physicians have found.